期刊文献+

前列腺增生患者年龄、前列腺体积以及血清PSA的关系分析 被引量:5

Study on the relationship between age,prostate volume and prostate specific antigen of patients with benign prostatic hyperplasia
下载PDF
导出
摘要 目的探讨前列腺增生患者年龄、前列腺体积以及血清前列腺特异性抗原(prostate-specific antigen,PSA)之间的关系。方法回顾2000~2005年204例确诊为前列腺增生的患者临床资料,采用SPSS10.0软件总结并分析患者年龄、前列腺体积以及血清PSA之间关系。结果204例患者平均年龄为(68.78±6.44)岁,平均体积为(57、33±34.12)ml;平均PSA值(6.90±5.81)μg·L^-1;对患者年龄分组后显示前列腺体积、血清PSA值随患者年龄增长而增加(F=3.05,P=0.03;F=2.74,P=0.044);血清PSA值随前列腺体积增加而升高(F=11.37,P〈0.001),对患者年龄进行控制后仍然显示PSA值与体积正相关(r=0.31,P〈0.001)。结论前列腺增生患者前列腺体积和血清PSA水平随患者年龄增长而增加,患者血清PSA与前列腺体积正相关。 Aim To discuss relationship between age,prostate volume and prostate specific antigen of patients with benign prostatic hyperplasia (BPH). Methods 204 cases of inpatients with BPH were retrospected, from 2000 to 2005. Data of patients ' age, prostate volume and serum PSA were collected and analyzed with software SPSS 10.0.,Results In all patients,age ranged from 55 to 92 years old (mean 68.78±6.44), prostate volume ranged from 20 to 193 ml (mean 57.33±34.12 ml), and value of PSA ranged from 0. 1 to 80. 2 μg·L^-1( mean 6.90±5.81 μg·L^-1). The prostate volume and the level of PSA ascend with age ( F = 3.05, P=0.03 ; F=2.74,P=0.044 ), as well as the level of PSA rise with the volume (F=7.34, P〈0. 001). There is a positive relationship between the prostate vol- ume and the level of PSA (r=0.31,P〈0.001). Conclusion Age is a risk factor to BPH, and age and prostate volume both affect the level of serum PSA.
出处 《安徽医药》 CAS 2008年第5期437-438,共2页 Anhui Medical and Pharmaceutical Journal
关键词 前列腺增生 年龄 前列腺体积 前列腺特异性抗原 benign prostatic hyperplasia age prostate volume PSA
  • 相关文献

参考文献9

  • 1McConnell JD. Prostatic growth:new insights into hormonal regulation[ J]. Br J Urol, 1995,76(suppll) :5 - 10.
  • 2谢辉,何秋香,黄慧聪,杨亦荣,朱启建,陈建欧,李澄棣,夏鹏,沈龙捷,王思齐.140例青年前列腺组织病理学研究[J].中华泌尿外科杂志,2006,27(11):755-757. 被引量:15
  • 3Berry MJ, Coffey DS, Walsh PC,et al. The development of human benign prostatic hyperplasia with age [ J ]. J Urol, 1984,132:474 - 8.
  • 4Homma Y, Kawabe K,TsukamotoT, et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the International Prostate Symptom Score [J].Int Urol, 1997,4:40 - 6.
  • 5肖丽梅.化学发光法检测前列腺特异性抗原对前列腺癌的诊断价值分析[J].安徽医药,2006,10(4):279-280. 被引量:12
  • 6Schroder FH, Kranse R. Verification bias and the prostate - specific antigen test is there a case for a lower threshold for biopsy [J].N Engl J Med ,2003 ,349 : 393 - 5.
  • 7Oesterling JE,Jacobsen SJ, Chute CG, et al. Serum prostate specific antigen in a community - based population of healthy men : establishment of age-specific reference ranges [J].J Am Med Assoc, 1993,270 :860 - 4.
  • 8Mochtar CA, Kiemeney LA, Van Riemsdijk MM, et al. Prostate - specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia[J]. Eur Urol,2003 ,44 :695 - 700.
  • 9Matsumoto K, Konishi N, Hiasy Y, et al. A highly sensitive enzyme - linked immunoassay for serum free prostate specific antigen ( f - PSA)[J]. Clin Chim Acta,1999 ,281:57 -69.

二级参考文献10

共引文献23

同被引文献65

引证文献5

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部